COCRYSTAL PHARMA, INC. Shareholders' Equity
COCRYSTAL PHARMA, INC. (COCP) had Shareholders' Equity of $1.04 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $1.04M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $4.12M.
- 2025-12-31: Stockholders' Equity Attributable to Parent $6.33M.
- 2025-09-30: Stockholders' Equity Attributable to Parent $7.67M.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2026-06-30 | $1.04M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $4.12M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $6.33M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $7.67M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $5.33M 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $7.30M 10-Q · filed 2026-08-13 | |
| 2024-12-31 | $9.52M 10-Q · filed 2026-08-13 | |
| 2024-09-30 | $12.70M 10-Q · filed 2025-11-14 | |
| 2024-06-30 | $17.39M 10-Q · filed 2025-11-14 | |
| 2024-03-31 | $22.59M 10-Q · filed 2025-11-14 | |
| 2023-12-31 | $26.38M 10-K · filed 2026-03-31 | |
| 2023-09-30 | $30.69M 10-Q · filed 2024-11-13 | |
| 2023-06-30 | $34.68M 10-Q · filed 2024-11-13 | |
| 2023-03-31 | $34.67M 10-Q · filed 2024-11-13 | |
| 2022-12-31 | $39.60M 10-K · filed 2025-03-31 | $39.57M 10-K · filed 2023-03-29 |
| 2022-09-30 | $49.91M 10-Q · filed 2023-11-13 | $43.91M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $49.39M 10-Q · filed 2023-11-13 | |
| 2022-03-31 | $73.58M 10-Q · filed 2023-11-13 | |
| 2021-12-31 | $77.55M 10-K · filed 2024-03-28 | |
| 2021-09-30 | $81.01M 10-Q · filed 2022-11-14 | |
| 2021-06-30 | $84.75M 10-Q · filed 2022-11-14 | |
| 2021-03-31 | $52.06M 10-Q · filed 2022-11-14 | |
| 2020-12-31 | $52.51M 10-K · filed 2023-03-29 | |
| 2020-09-30 | $50.18M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $37.05M 10-Q · filed 2021-11-15 | |
| 2020-03-31 | $40.43M 10-Q · filed 2021-11-15 | |
| 2019-12-31 | $25.71M 10-K · filed 2022-03-23 | |
| 2019-09-30 | $70.75M 10-Q · filed 2020-11-13 | |
| 2019-06-30 | $72.42M 10-Q · filed 2020-11-13 | |
| 2019-03-31 | $73.82M 10-Q · filed 2020-11-13 | |
| 2018-12-31 | $66.89M 10-K · filed 2021-03-17 | |
| 2018-09-30 | $110.90M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $112.65M 10-Q · filed 2019-11-12 | $112.65M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $104.14M 10-Q · filed 2019-11-12 | $104.14M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $105.40M 10-K · filed 2020-03-27 | |
| 2017-09-30 | $100.00M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $102.04M 10-Q · filed 2017-08-08 | |
| 2017-03-31 | $99.98M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $102.32M 10-K · filed 2019-04-01 | |
| 2016-09-30 | $167.82M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $166.83M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $169.34M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $167.59M 10-K · filed 2018-03-21 | |
| 2015-09-30 | $196.75M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $196.52M 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $188.70M 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $6.65M 10-K · filed 2018-03-21 | |
| 2014-09-30 | $3.98M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $6.06M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | -$2.07M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | -$8.83M 10-K · filed 2017-03-31 | -$6.03M 10-K · filed 2014-03-31 |
| 2013-09-30 | -$10.45M 10-Q · filed 2013-11-18 | |
| 2013-06-30 | -$5.29M 10-Q · filed 2013-08-15 | |
| 2013-03-31 | -$5.06M 10-Q · filed 2013-05-10 | |
| 2012-12-31 | -$5.01M 10-K · filed 2015-03-31 | -$3.58M 10-K · filed 2013-04-01 |
| 2012-09-30 | -$74.93K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | -$3.93M 10-Q/A · filed 2012-09-28 | |
| 2012-03-31 | -$5.77M 10-Q/A · filed 2012-10-02 | |
| 2011-12-31 | -$2.77M 10-K · filed 2014-03-31 | |
| 2011-09-30 | -$177.71K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $366.26K 10-Q/A · filed 2011-09-09 | |
| 2010-12-31 | -$589.20K 10-K · filed 2013-04-01 | -$522.13K 10-Q/A · filed 2011-09-09 |
| 2009-12-31 | -$226.36K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |